Login

Hantz Group employs a holistic approach to provide clients with comprehensive financial, estate, and tax planning solutions. 00:10:00

Share On Facebook Share On Twitter

John Hantz - Chief Executive Officer - Hantz Holdings llc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Enabling exceptional founders to build startups and great companies|Antoine Poirson,Partner, France,Antler
00:10:00
Jed Miller – Expert in Capital Relief Trades and Subscription Facilities at Cadwalader
00:10:00
Inside Look: Meet the Dynamic Team at D. E. Shaw Group's London Office
00:10:00
Pierre Barnabé of Soitec confirms the semiconductor company's roadmap for 2025-2026 in an interview on BFM Business.
00:10:00
Battery Industry Overview: Automotive Forecast and Raw Material Demand Projections
00:10:00
Key Updates on Concessions, Commodity Impacts, and U.S. Critical Minerals Strategy
00:10:00
Li-Cycle CEO emphasizes top priority with scaled-back Rochester Hub and outlines a three-point plan.
00:10:00
A Financial Analyst at SilverStone Group, Inc. holding a Chemistry bachelor's degree and an MBA from Creighton University.
00:10:00
Mark Partin of BlackLine on Navigating the Future of Finance and Customer Relationships | Mark Partin, CFO, BlackLine Inc.
00:10:00
Jonathan Eig on Martin Luther King Jr.'s Radical Legacy and Media Misrepresentation|Jonathan Eig,Professor,Medill School of Journalism
00:10:00
Investment vehicle to empower historically overlooked people|Serena Williams,CEO,Serena Ventures
00:10:00
In a conversation with Andy Headley of Veritas Asset Management, the potential of UK equities in the pharmaceutical sector is explored.

© 2017 - Neuhu+